PinkDx is an early-stage company focused on addressing the medical problems that women uniquely face by applying sophisticated scientific approaches to resolve them and providing answers that have an immediate, positive impact on their lives. The company's first indication will focus on overcoming diagnostic challenges for women who present with general symptoms that could signal a gynecological cancer.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/25/24 | $40,000,000 | Series A |
Byers Capital Catalio Capital  Mayo Clinic Mountain Group Partners The Production Board | undisclosed |
